Sophia Genetics SA (SOPH): Price and Financial Metrics Recent IPO


Sophia Genetics SA (SOPH): $17.78

-0.14 (-0.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SOPH Stock Price Chart Interactive Chart >

Price chart for SOPH

SOPH Price/Volume Stats

Current price $17.78 52-week high $19.80
Prev. close $17.92 52-week low $14.88
Day low $17.08 Volume 54,200
Day high $18.54 Avg. volume 145,617
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 1.13B

Sophia Genetics SA (SOPH) Company Bio


Sophia Genetics SA, a cloud-based software-as-a-service platform that enables healthcare institutions to get insights from their data. The company offers SOPHiA DDM for solid tumors. Sophia Genetics SA was founded in 2012 and is based in Saint-Sulpice, Switzerland.


SOPH Latest News Stream


Event/Time News Detail
Loading, please wait...

SOPH Latest Social Stream


Loading social stream, please wait...

View Full SOPH Social Stream

Latest SOPH News From Around the Web

Below are the latest news stories about SOPHiA GENETICS SA that investors may wish to consider to help them evaluate SOPH as an investment opportunity.

SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance

BOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. Recent Highlights Revenue was $10.2 million for the second quarter, representing a 72% increase over the corresponding period of 2020Increased total customer base of hospitals, labs, and biopharma institutions to 780 customers during the second quarter, up from 750 in the first quarter of 2021Strengthened balance sheet

Yahoo | September 9, 2021

SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference. SOPHiA GENETICS’ management is scheduled to present on Friday, September 10th at 9:30 a.m. Eastern Time/3:30 p.m. Central European Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: ir.sophiagenet

Yahoo | August 30, 2021

SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The companys management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook.

Intrado Digital Media | August 26, 2021

UPDATE SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The companys management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook.

Intrado Digital Media | August 26, 2021

UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The company’s management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of th

Yahoo | August 26, 2021

Read More 'SOPH' Stories Here

SOPH Price Returns

1-mo -2.25%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7349 seconds.